Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Dupixent pipelines NO.4 Eliquis Company: BMS/Pfizer 2024 worldwide sales forecast: $13.31 billion Eliquis (apixaban) is an orally administered selective factor Xa inhibitor jointly developed by BMS and Pfizer, starting in 2007
References 1 KellerSFMandellBF
HR 0.93
doi: 10.1186/s12964-017-0172-3
Look for transparent labeling, realistic claims, third-party testing where available, and professional guidance if you have a medical condition or take medications
US$ 24.73
US$ 23.09
US$ 22.21
US$ 29.00
US$ 29.19
